Most common causes of short stature in children

Authors

  • Aleksandra Jančevska Sveučilišna dječja klinika, Medicinski fakultet Skoplje

DOI:

https://doi.org/10.13112/pc.1249

Keywords:

Growth Disorders; Growth Hormone; Gestational Age; Natriuretic Peptide, C-Type; Molecular Diagnostic Techniques

Abstract

Correct linear growth is a characteristic of a healthy child. Any deviation from the normal/expected growth for an individual is a signal that something is happening. A child with short stature has a current height below the 3rd percentile on the growth curve or below 2.0 SDS for their gender and current age. It should be investigated, and the cause of stunted growth determined. Physiological short stature is the most common, presenting as constitutional growth retardation and the so-called familial short stature. However, it can also be pathologically short stature, caused by non-endocrine (chronic diseases of the blood, kidneys, heart, etc., malnutrition, inherited metabolic diseases, syndromes) and endocrinological (growth hormone deficiency, hypothyroidism, multiple hormone deficiencies, idiopathic short stature, etc.) causes. Children born small for gestational age (SGA) also belong to a special category. Using advanced molecular diagnostic techniques, many pathogenic variants in genes are now known to be associated with isolated short stature in individuals or families. Short stature can be proportional and disproportionate, depending on the child's body structure.

Adequate monitoring of growth during childhood, an early assessment of short stature, detection of the causes of its occurrence, and timely treatment can prevent short adult height.

References

1. Rosenfeld RG. Insulin-like growth factors and the basis of growth. N Engl J Med. 2003 4;349:2184-6.

2. Grummer-Strawn LM, Reinold C, Krebs NF, Centers for Disease Control and Prevention (CDC). Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep. 2010;59:1–15.

3. Stochholm K, Gravholt CH, Laursen T, Jørgensen JO, Laurberg P, Andersen M, et al. Incidence of GH deficiency—a nationwide study. European Journal of Endocrinology/European Federation of Endocrine Societies 2006;155:61–71.

4. Krakow D, Rimoin DL. The skeletal dysplasias. Genet Med. 2010;12:327–41.

5. Zabel B. FGFR3-Mutationen als Ursache von Skelletdysplasien der Achondroplasie-Gruppe - Aufklärung der gestörten Signalwege in der Wachstumsfuge [FGFR3-Mutations as a cause of skeletal dysplasia of the achondroplasia group - alucidation of disturbed signal pathways in the growth plate]. In: Mohnike K, Klingebiel KH, Vaupel N, Zabel B, editors. Achondroplasie und Hypochondroplasie - Diagnostik und Betreuung spezifischer Kleinwuchsformen [achondroplasia and Hypochondroplasia - diagnostic and care of specific forms of short stature]: ABW Wissensverlagsgesellschaft; 2013. p. 3–10.

6. Patel R, Bajpai A. Evaluation of Short Stature in Children and Adolescents. Indian J Pediatr. 2021;88:1196-202.

7. Chan Y, Salem RM, Hsu Y-HH, McMahon G, Pers TH, Vedantam S, et al. Genome-wide analysis of body proportion classifies height-associated variants by mechanism of action and implicates genes important for skeletal development. Am J Hum Genet. 2015;96:695–708.

8. Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, et al. Rare and low-frequency coding variants alter human adult height. Nature. 2017;542:186–90.

9. Macé A, Tuke MA, Deelen P, Kristiansson K, Mattsson H, Nõukas M, et al. CNV-association meta-analysis in 191,161 European adults reveals new loci associated with anthropometric traits. Nat Commun. 2017;8:744.

10. Gkourogianni A, Andrew M, Tyzinski L. Clinical characterization of patients with Autosomal Dominant Short Stature due to Aggrecan Mutations. J Clin Endocrinol Metab. 2017;102:460–9.

11. Temtamy SA, Aglan MS. Brachydactyly. Orphanet J Rare Dis. 200813;3:15.

12. Will AJ, Cova G, Osterwalder M, Chan W-L, Wittler L, Brieske N, et al. Composition and dosage of a multipartite enhancer cluster control developmental expression of Ihh (Indian hedgehog). Nat Genet. 2017;49:1539– 45.

13. Chinoy A, Murray PG. Diagnosis of growth hormone deficiency in the paediatric and transitional age. Best Pract Res Clin Endocrinol Metab. 2016;30:737–47

14. Alkalay AL, Graham Jr JM, Pomerance JJ. Evaluation of neonates born with intrauterine growth retardation: review and practise guiedelines. J Perinatol. 1998;18:142-51.

15. Lee PA, Chernausek SD, Hokken-Koleaga AC, Czernikow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age April 24 - October 1, 2001. Pediatrics 2001;111:1253–61.

16. Verkauskiene R, Albertsson Wikland K, Niklasson A. Variation in a size at birth in infants born small for gestational age in Lithuania. Acta Pediat.r 2002;91:329-34.

17. Saenger P, Czernichow P, Hughes I, Reiter EO: Small for gestational age: short stature and beyond. Endocr Rev. 2007;28:219–51.

18. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A: Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Paediatric Endocrinology and theGrowth Hormone Research Society. J Clin Endocrinol Metab. 2007;92:804–10.

19. Luo ZC, Albertsson-Wikland K, Karlberg J. Length and body mass index at birth and target height influences patterns of postnatal growth in children born small for gestational age. Paediatrics. 1998;102:E72.

20. Jensen SM, Ritz C, Ejlerskov KT, Molgaard C, Michaelsen KF. Infant BMI peak, breastfeeding, and body composition at age 3y. Am J Clin Nutr 2015;101:319–25.

21. Pfäffle R, Kiess W, Klammt J. Downstream insulin-like growth factor. Endocr Dev. 2012;23:42-51.

22. Randhawa RS. The insulin-like growth factor system and fetal growth restriction. Pediatr Endocrinol Rev. 2008;6:235-40.

23. Jancevska A, Gucev ZS, Tasic V, Pop-Jordanova N. Growth hormone deficiency (GHD) and small for gestational age (SGA): genetic alterations. Prilozi. 2009;30:33-55.

24. Janchevska A, Krstevska Konstantinova M, Pfäffle H, Schlicke M, Laban N, Tasic V, et al. IGF1R Gene Alterations in Children Born Small for Gestitional Age (SGA). Open Access Maced. J Med Sci. 2018;10:2040–4.

25. Janchevska A, Dimovski A, Mironska K, Tasic V, Gucev Z. IGF1R Gene Alterations in Small for Gestational Age (SGA) Children. Open Access Maced J Med Sci. 2018;6:790–3.

26. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, et al. IGF-I receptor mutations resulting in postnatal growth retardation intrauterine and. N Engl J Med. 2003;349:2211-22.

27. Janchevska A, Gucev Z, Tasevska-Rmus L, Tasic V. Congenital Anomalies of the Kidney and Urinary Tract in Children Born Small for Gestational Age. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2017;38:53-7.

28. Janchevska A, Gucev Z, Tasic V, Polenakovic M. Homeostasis Model Assessment - Insulin Resistance and Sensitivity (HOMA-IR and IS) Index in Overweight Children Born Small for Gestational Age (SGA). Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2018;39:83-9.

29. Dahlberg PS, Mosdøl A, Ding KY, Bleka Ø, Rolseth V, Straumann GH, et al. Agreement Between Chronological Age and Bone Age Based on the Greulich and Pyle Atlas for Age Estimation: A Systematic Review [Internet]. Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH). Oslo; Norway: 2017.

30. Tsai S, Laffan E. Congenital Growth Hormone Deficiency – A Review with a Focus on Neuroimaging. Eur Endocrinol. 2013;9:136-40.

31. Dattani MT. Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Clin Endocrinol (Oxf). 2005;63:121–30.

32. Mehta A, Dattani MT. Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism. Best Pract Res Clin Endocrinol Metab. 2008;22:191–206.

33. Alatzoglou KS, Dattani MT. Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev. 2009;85:705–12.

34. Hee Jee Y, Baron J, Nilsson O. New developments in the genetic diagnosis of short stature. Curr Opin Pediatr. 2018;30:541–7.

35. Plachy L, Amaratunga SA, Dusatkova P, Maratova K, Neuman V, Petruzelkova L, et al. Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us? Front Endocrinol (Lausanne). 2023;13:1102968.

36. Roztoczyńska D, Kot-Marchewczyk A, Wędrychowicz A, Dobosz A, Starzyk J. Indications for genetic diagnosis in children with growth hormone deficiency and born small for gestational age. Pediatr Endocrinol Diabetes Metab. 2024;30:51-60.

37. Rohayem Ј, Drechsel H, Tittel B, Hahn G, Pfaeffle R, Huebner A. Long-Term Outcomes, Genetics, and Pituitary Morphology in Patients with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies: A Single-Centre Experience of Four Decades of Growth Hormone Replacement. Horm Res Paediatr. 2016;86:106-16.

38. Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr. 2016;86:361–97.

39. Society GR. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society 1. J Clin Endocrinol Metab. 2000;85:3990–3.

40. Janchevska A, Krstevska-Konstantinova M, Tasic V, Gucev Z. Growth Hormone Treatment in Children Born Small for Gestational Age (SGA). Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2018 1;39:143-9.

41. Chinoy A, Murray PG. Diagnosis of growth hormone deficiency in the paediatric and transitional age. Best Pract Res Clin Endocrinol Metab. 2016;30:737-47.

42. Mastromauro C, Giannini C, Chiarelli F. Short stature related to Growth Hormone Insensitivity (GHI) in childhood. Front Endocrinol (Lausanne). 2023;14:1141039.

43. Wang K, Ye F, Wang DY, Lai PJ, Zhang LQ. Aromatase inhibitors for short stature in male children and adolescents treated with growth hormone: a meta-analysis of randomized controlled trials. BMC Pediatr. 2024;24:813.

44. Witt S, Kolb B, Bloemeke J, Mohnike K, Bullinger M, Quitmann J. Quality of life of children with achondroplasia and their parents - a German cross-sectional study. Orphanet J Rare Dis. 2019;14:194.

Published

2026-04-03

How to Cite

Jančevska, A. (2026). Most common causes of short stature in children. Paediatria Croatica, 70(suppl 3), 63-71. https://doi.org/10.13112/pc.1249

Similar Articles

101-110 of 214

You may also start an advanced similarity search for this article.